Frontlight ResearchEarly access
TerminatedNo phase
Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty
Key facts
- Who runs it
- Zimmer Biomet
- Where
- Austin, Birmingham, Hampton, Nashville, San Diego, and Virginia Beach, United StatesSee the 6 sites
- Trial code
- Status
- Terminated
- People taking part
- 206 people enrolled
- Started
- 20 Feb 2017
- Ended
- 4 Dec 2024
- Type of study
- Observational
- Treatments tested
- Surgery
- Record updated
- 5 February 2025
- Why it stopped
- Data collected up to this point has provided sufficient follow-up and will allow for a reasonable estimate of the five-year survivorship rate for the Echo Bi-Metric Microplasty stem in primary total hip arthroplasty.
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Subjects are eligible for this trial if they satisfy all of the following criteria:; Patient is 18 to 65 years of age, inclusive; Patient is skeletally mature; Patient qualifies for primary unilateral or bilateral total hip arthroplasty based on physical exam and medical history including at least one of the following:; Osteoarthritis; Avascular necrosis; Rheumatoid arthritis; Correction of functional deformity; Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques; Patient has no history of previous total hip arthroplasty or arthrodesis of the affected hip joint(s); Patient is willing and able to complete scheduled follow-up evaluations as described in the Informed Consent; Patient, or the patient's legally authorized representative, has participated in the Informed Consent process and is willing and able to sign an IRB- approved informed consent
Who cannot take part
- Subjects will be excluded from this trial if they satisfy any of the following criteria as determined by the research staff or in the judgment of the treating physician:; Patient has a total prosthetic hip replacement device (including surface replacement arthroplasty, endoprosthesis, etc.) in the affected hip joint(s); Patient is septic or has an active infection; Patient is uncooperative patient or is incapable of following directions; Patient is diagnosed with osteoporosis; Patient is diagnosed with a metabolic disorder which may impair bone formation; Patient is diagnosed with osteomalacia; Patient has distant foci of infections which may spread to the implant site
Where in United States
- Growth OrthoAustin, United States
- OrthoSports AssociatesBirmingham, United States
- Tidewater OrthpaedicsHampton, United States
- Southern Joint Replacement InstituteNashville, United States
- University of CA - San DiegoSan Diego, United States
- Jordan Young InstituteVirginia Beach, United States
About the trial
What the trial wants to find out
The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
Treatments tested
- Surgery
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 5 February 2025